ALPHA10X is an AI-powered investment platform designed for a wide range of technology investor classes and public/private organizations. The AI discovers signals and insights into big data and shapes them into knowledge, connections, scores, and predictions. It accelerates innovation and increases ROI by precision-targeting capital at the startups that promise to deliver maximum impact. It cuts research time and cost by 75% and improves ROI and impact outcomes by delivering predictive accuracy of over 80%, looking 3-years into the future. We are to impact investment what social media is to friendship.
Headquartered in Europe’s leading cleantech cluster in Aix-en-Provence in the South of France, the team includes top academics, former Silicon Valley executives, and engineers with advanced degrees from elite engineering schools.
Headquartered in Europe’s leading cleantech cluster in Aix-en-Provence in the South of France, the team includes top academics, former Silicon Valley executives, and engineers with advanced degrees from elite engineering schools.
Location: France, Provence-Alpes-Cote d'Azur, Aix-en-Provence
Total raised: $9.4M
Investors 1
| Date | Name | Website |
| - | FinTech Sa... | fintechsan... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.02.2022 | Seed | $9.4M | - |
Mentions in press and media 2
| Date | Title | Description |
| 21.02.2022 | Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus, CEO and Founder of ALPHA10X | Share Tweet Share Share Email ALPHA10X is an innovative AI-powered search and discovery platform using state-of-the-art scientific methods to extract insights from data and shape them into knowledge, connections, and scores that inform futu... |
| 01.02.2022 | ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding and Expands Leadership Team to Bring Artificial Intelligence to Life Sciences Investment | SCOTTSDALE, Ariz., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Life science is a vast, entangled system that blurs the lines between the physical, digital, and biological. Public policymakers, investors across asset classes, and business leaders, lac... |